logo

Dr Reddy's Laboratories Ltd. (RDY)



Trade RDY now with
  Date
  Headline
8/11/2020 12:33:13 AM Dr. Reddy's Announces Launch Of Ciprofloxacin 0.3% And Dexamethasone 0.1% Otic Suspension, USP
7/29/2020 6:50:34 AM Dr. Reddy's Q1 EPS $0.46 Vs $0.53 Last Year
7/14/2020 4:48:37 AM Dr. Reddy's Laboratories Unveils Over-The-Counter Nicotine Polacrilex Lozenges In The U.S. Market
7/1/2020 4:14:44 AM Dr. Reddy's Partners With FUJIFILM And Global Response Aid For Development Of Avigan(r) Tablets
6/19/2020 5:42:05 AM Dr. Reddy's Laboratories Launches Abiraterone Acetate Tablets USP, 250 Mg In The U.S. Market
6/13/2020 6:12:39 AM Dr. Reddy's Laboratories Enters Licensing Agreement With Gilead Sciences For Remdesivir
6/12/2020 7:49:45 AM Dr. Reddy's Laboratories Announces Launch Of Colchicine Tablets USP, 0.6 Mg In U.S. Market
6/10/2020 5:52:16 AM Dr. Reddy's Laboratories Completes Acquisition Of Select Business Divisions Of Wockhardt
5/20/2020 6:50:00 AM Dr. Reddy's Q4 Revenue Rs. 4,432 Cr, Up 10% From Last Year
5/6/2020 3:41:02 AM Dr. Reddy's Laboratories Unveils Desmopressin Acetate Injection USP, 4 Mcg/mL In The U.S. Market
4/27/2020 3:26:31 AM Dr. Reddy's Laboratories Unveils Fenofibrate Tablets USP, In The U.S. Market
4/14/2020 5:23:41 AM Dr. Reddy's Announces Launch Of Authorized Generic Version Of NitroDur Transdermal Infusion System